Carboplatin combined with arsenic trioxide versus carboplatin combined with docetaxel treatment for LACC: A randomized, open-label, phase II clinical study

This study compared the efficacy and safety of carboplatin combined with arsenic trioxide versus carboplatin combined with docetaxel in treating locally advanced cervical cancer (LACC).

Saved in:
Bibliographic Details
Main Authors: Li Sijin, Zhang Yawen, Li Haiying, He Zeyang, Li An, Yan Jiao, Li Daocheng
Format: Article
Language:English
Published: De Gruyter 2024-12-01
Series:Open Medicine
Subjects:
Online Access:https://doi.org/10.1515/med-2024-1106
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846120500301922304
author Li Sijin
Zhang Yawen
Li Haiying
He Zeyang
Li An
Yan Jiao
Li Daocheng
author_facet Li Sijin
Zhang Yawen
Li Haiying
He Zeyang
Li An
Yan Jiao
Li Daocheng
author_sort Li Sijin
collection DOAJ
description This study compared the efficacy and safety of carboplatin combined with arsenic trioxide versus carboplatin combined with docetaxel in treating locally advanced cervical cancer (LACC).
format Article
id doaj-art-433469aac3e7426cb180384bd1c138dc
institution Kabale University
issn 2391-5463
language English
publishDate 2024-12-01
publisher De Gruyter
record_format Article
series Open Medicine
spelling doaj-art-433469aac3e7426cb180384bd1c138dc2024-12-16T08:57:24ZengDe GruyterOpen Medicine2391-54632024-12-011914576510.1515/med-2024-1106Carboplatin combined with arsenic trioxide versus carboplatin combined with docetaxel treatment for LACC: A randomized, open-label, phase II clinical studyLi Sijin0Zhang Yawen1Li Haiying2He Zeyang3Li An4Yan Jiao5Li Daocheng6Medical Department of Obstetrics and Gynecology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510000, Guangdong, ChinaGynecology, Baiyun Branch of the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, ChinaGynecology, Zhuhai Branch of Guangdong Provincial Hospital of Traditional Chinese Medicine, Zhuhai, Guangdong, ChinaGynecology, Beijing University of Chinese Medicine Shenzhen Hospital (Longgang), Shenzhen, Guangdong, ChinaMedical Department of Obstetrics and Gynecology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510000, Guangdong, ChinaRespiratory Department, Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, Guangdong, ChinaMedical Department of Obstetrics and Gynecology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510000, Guangdong, ChinaThis study compared the efficacy and safety of carboplatin combined with arsenic trioxide versus carboplatin combined with docetaxel in treating locally advanced cervical cancer (LACC).https://doi.org/10.1515/med-2024-1106locally advanced cervical cancerarsenic trioxidecarboplatindocetaxelneoadjuvant chemotherapy
spellingShingle Li Sijin
Zhang Yawen
Li Haiying
He Zeyang
Li An
Yan Jiao
Li Daocheng
Carboplatin combined with arsenic trioxide versus carboplatin combined with docetaxel treatment for LACC: A randomized, open-label, phase II clinical study
Open Medicine
locally advanced cervical cancer
arsenic trioxide
carboplatin
docetaxel
neoadjuvant chemotherapy
title Carboplatin combined with arsenic trioxide versus carboplatin combined with docetaxel treatment for LACC: A randomized, open-label, phase II clinical study
title_full Carboplatin combined with arsenic trioxide versus carboplatin combined with docetaxel treatment for LACC: A randomized, open-label, phase II clinical study
title_fullStr Carboplatin combined with arsenic trioxide versus carboplatin combined with docetaxel treatment for LACC: A randomized, open-label, phase II clinical study
title_full_unstemmed Carboplatin combined with arsenic trioxide versus carboplatin combined with docetaxel treatment for LACC: A randomized, open-label, phase II clinical study
title_short Carboplatin combined with arsenic trioxide versus carboplatin combined with docetaxel treatment for LACC: A randomized, open-label, phase II clinical study
title_sort carboplatin combined with arsenic trioxide versus carboplatin combined with docetaxel treatment for lacc a randomized open label phase ii clinical study
topic locally advanced cervical cancer
arsenic trioxide
carboplatin
docetaxel
neoadjuvant chemotherapy
url https://doi.org/10.1515/med-2024-1106
work_keys_str_mv AT lisijin carboplatincombinedwitharsenictrioxideversuscarboplatincombinedwithdocetaxeltreatmentforlaccarandomizedopenlabelphaseiiclinicalstudy
AT zhangyawen carboplatincombinedwitharsenictrioxideversuscarboplatincombinedwithdocetaxeltreatmentforlaccarandomizedopenlabelphaseiiclinicalstudy
AT lihaiying carboplatincombinedwitharsenictrioxideversuscarboplatincombinedwithdocetaxeltreatmentforlaccarandomizedopenlabelphaseiiclinicalstudy
AT hezeyang carboplatincombinedwitharsenictrioxideversuscarboplatincombinedwithdocetaxeltreatmentforlaccarandomizedopenlabelphaseiiclinicalstudy
AT lian carboplatincombinedwitharsenictrioxideversuscarboplatincombinedwithdocetaxeltreatmentforlaccarandomizedopenlabelphaseiiclinicalstudy
AT yanjiao carboplatincombinedwitharsenictrioxideversuscarboplatincombinedwithdocetaxeltreatmentforlaccarandomizedopenlabelphaseiiclinicalstudy
AT lidaocheng carboplatincombinedwitharsenictrioxideversuscarboplatincombinedwithdocetaxeltreatmentforlaccarandomizedopenlabelphaseiiclinicalstudy